Tom 15, Nr 3 (2019)
Inne materiały uzgodnione z Redakcją
Opublikowany online: 2019-10-22
Wyświetlenia strony
461
Wyświetlenia/pobrania artykułu
340
Przegląd piśmiennictwa
Pol. Przegl. Neurol 2019;15(3):185-186.
Streszczenie
Brak
Referencje
- Scappaticcio L, Castellana M, Virili C, et al. Alemtuzumab-induced thyroid events in multiple sclerosis: a systematic review and meta-analysis. J Endocrinol Invest. 2019 [Epub ahead of print].
- Ivashynka A, Copetti M, Naldi P, et al. The impact of lifetime alcohol and cigarette smoking loads on multiple sclerosis severity. Front Neurol. 2019; 10: 866.
- Thirupathi A, Chang YZ. Brain iron metabolism and CNS diseases. Adv Exp Med Biol. 2019; 1173: 1–19.
- Castagnoli H, Manni C, Marchesani F, et al. The role of 18F-FDG PET/CT in management of paraneoplastic limbic encephalitis combined with small cell lung cancer: A case report. Medicine (Baltimore). 2019; 98(35): e16593.
- Wei EX, Oh ES, Harun A, et al. Increased prevalence of vestibular loss in mild cognitive impairment and Alzheimer's disease. Curr Alzheimer Res. 2019 [Epub ahead of print].
